title: Careless talk may cost lives in attributing adverse events to ADP receptor antagonists.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Green
authors.forename: Martin
authors.initials: M
authors.lastname: Iveson
authors.forename: Robert
authors.initials: R
authors.lastname: Crook
authors.forename: Nichola
authors.initials: N
authors.lastname: Burrows
authors.forename: Andrew K S
authors.initials: AK
authors.lastname: Gough
mesh_terms: D001168:Arthritis / Q000139:chemically induced*; D000077144:Clopidogrel; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D058919:Purinergic P2 Receptor Antagonists; D013988:Ticlopidine / Q000009:adverse effects* / Q000031:analogs & derivatives
chemical_list: D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D000077144:Clopidogrel; D013988:Ticlopidine